Sevoflurane-based enhancement of phase-amplitude coupling and localization of the epileptogenic zone

Keiko Wada, Masaki Sonoda, Ethan Firestone, Kazuki Sakakura, Naoto Kuroda, Yutaro Takayama, Keiya Iijima, Masaki Iwasaki, Takahiro Mihara, Takahisa Goto, Eishi Asano, Tomoyuki Miyazaki

Abstract

Objective: Phase-amplitude coupling between high-frequency (≥150 Hz) and delta (3-4 Hz) oscillations—measured as the modulation index (MI)—is a promising, objective biomarker of epileptogenicity. This study investigated whether sevoflurane anesthesia preferentially enhances this metric within the epileptogenic zone (EZ) to improve surgical localization.

Methods: In this observational study, intraoperative electrocorticography (ECoG) data were analyzed from 621 electrodes chronically implanted in eight patients with drug-resistant focal epilepsy. All patients underwent resective surgery under sevoflurane anesthesia and subsequently achieved seizure control. Brain sites were classified as 'removed' (epileptogenic) or 'retained' (non-epileptogenic). Mixed model analysis determined which anesthetic stage optimized MI-based classification.

Results: MI increased as a function of anesthetic depth, from baseline to 2 minimum alveolar concentration (MAC) of sevoflurane, preferentially at sites with higher initial MI values. This effect peaked just prior to reaching 2 MAC, where the odds of a site being classified as epileptogenic increased 86.6 times for every 1-unit increase in MI.

Conclusions: Intraoperative MI best localized the EZ immediately before sevoflurane reached 2 MAC. This suggests that sevoflurane acts as a neural "contrast agent," potentially reducing the need for lengthy extraoperative invasive evaluations.

Introduction

For patients with drug-resistant focal epilepsy, neurosurgical resection of the epileptogenic zone (EZ)—the area where seizures originate—is often the only path to seizure freedom. However, precisely mapping the boundaries of the EZ remains a significant clinical challenge. While intraoperative electrocorticography (ECoG) is commonly used to identify interictal spikes, manual interpretation is subjective, time-consuming, and prone to human error.

Recent research has turned toward objective biomarkers, specifically phase-amplitude coupling (PAC). This study explores the use of the Modulation Index (MI), which quantifies how high-frequency oscillations (HFOs, ≥150 Hz) are nested within the phase of slower delta waves (3-4 Hz). By observing how sevoflurane anesthesia modulates these signals, researchers aimed to identify a more reliable, automated method for real-time surgical guidance.

Methods

The study analyzed 621 electrodes from eight pediatric and young adult patients (ages 4–22). A critical component of the study design was the "ground truth" validation: all eight patients achieved ILAE Class 1 outcomes (complete seizure freedom) at least 12 months post-surgery, confirming that the resected tissue indeed contained the EZ.

Researchers tracked MI changes across five distinct stages of sevoflurane administration:

  1. Baseline: Oxygen only (wakefulness).
  2. Induction Phases: Divided into the first, middle, and last thirds of the ramp-up period.
  3. Maintenance: 2.0 MAC (deep anesthesia).

MI was quantified using the open-source winPACT computational toolbox. This automated approach allowed for rapid analysis—approximately 1.2 seconds per channel—compared to the 90 seconds typically required for manual HFO counting.

Results and Discussion

The "Contrast Agent" Effect

The study’s most significant finding was that sevoflurane does not increase MI uniformly across the brain. Instead, it acts as a "contrast agent," preferentially boosting MI in regions that already exhibit higher baseline coupling. By "turning up the volume" on these specific signals, the anesthetic makes the EZ significantly more visible against the background of healthy brain tissue.

The Optimal Diagnostic Window

The ability to discriminate between epileptogenic and healthy tissue was not constant. The predictive power peaked during the "last 1/3" stage of induction—the two-minute window immediately preceding deep anesthesia (2.0 MAC). During this window, the statistical odds of a site being part of the EZ increased by a factor of 86.6 for every 1-unit increase in MI. Receiver Operating Characteristic (ROC) analysis during this stage yielded an Area Under the Curve (AUC) of 0.71.

Biological Mechanisms: Paradoxical Excitation

The researchers hypothesize that this enhancement is driven by the unique neurobiology of epileptic tissue. In many patients with focal epilepsy, chloride transporters like NKCC1 are upregulated, while KCC2 is downregulated. This imbalance can cause GABA, typically an inhibitory neurotransmitter, to have a paradoxical excitatory effect. Because sevoflurane works primarily by enhancing GABAergic receptors, it may inadvertently trigger increased activity in the EZ while suppressing the rest of the brain.

Clinical Significance and Limitations

The speed of MI calculation (1.2 seconds per channel) suggests that this method could be integrated into real-time surgical workflows, providing surgeons with an objective map of the EZ while the patient is on the table. This could potentially reduce the need for long-term, extraoperative invasive monitoring, which carries its own risks and costs.

However, the study is limited by its small cohort size (n=8). Additionally, the researchers noted that certain healthy brain regions, such as the occipital cortex, naturally exhibit higher MI, which could lead to false positives. Future work will focus on developing a "normative atlas" of MI under anesthesia to help clinicians distinguish between naturally high-signal areas and truly epileptogenic tissue. Larger prospective trials are required to validate these findings before MI-based mapping can become a standard of care in epilepsy surgery.

Summary updated

Abstract

ABSTRACT Objective Phase-amplitude coupling between high-frequency (≥150 Hz) and delta (3-4 Hz) oscillations - modulation index (MI) - is a promising, objective biomarker of epileptogenicity. We determined whether sevoflurane anesthesia preferentially enhances this metric within the epileptogenic zone. Methods This is an observational study of intraoperative electrocorticography data from 621 electrodes chronically implanted into eight patients with drug-resistant, focal epilepsy. All patients were anesthetized with sevoflurane during resective surgery, which subsequently resulted in seizure control. We classified ‘removed’ and ‘retained’ brain sites as epileptogenic and non-epileptogenic, respectively. Mixed model analysis determined which anesthetic stage optimized MI-based classification of epileptogenic sites. Results MI increased as a function of anesthetic stage, ranging from baseline (i.e., oxygen alone) to 2 minimum alveolar concentration (MAC) of sevoflurane, preferentially at sites showing higher initial MI values. This phenomenon was accentuated just prior to sevoflurane reaching 2 MAC, at which time, the odds of a site being classified as epileptogenic were enhanced by 86.6 times for every increase of 1 MI. Conclusions Intraoperative MI best localized the epileptogenic zone immediately before sevoflurane reaching 2 MAC in this small cohort of patients. Significance Prospective, large cohort studies are warranted to determine whether sevoflurane anesthesia can reduce the need for extraoperative, invasive evaluation. Highlights - We measured the modulation index on intraoperative electrocorticography recording. - Sevoflurane enhanced the modulation index differentially across the epileptogenic and non- epileptogenic sites. - The modulation index best discriminated these two groups of sites before sevoflurane reached 2 minimum alveolar concentration.
BibTeX
@inproceedings{wada2021sevoflurane,
  author = {Keiko Wada and Masaki Sonoda and Ethan Firestone and Kazuki Sakakura and Naoto Kuroda and Yutaro Takayama and Keiya Iijima and Masaki Iwasaki and Takahiro Mihara and Takahisa Goto and Eishi Asano and Tomoyuki Miyazaki},
  title = {{Sevoflurane-based enhancement of phase-amplitude coupling and localization of the epileptogenic zone}},
  booktitle = {Clinical},
  year = {2021},
  doi = {10.1016/j.clinph.2021.11.004},
}
Figure